Blood Vision will be available in all 50 states starting next Tuesday, offering users insights across over 120 biomarkers and integrating with Ultrahuman’s wearable technology
Ultrahuman, known for its wearable health tracking devices, is launching a new platform called Blood Vision today. The product, which will be available across the U.S., is designed to offer a more detailed look into a person’s health by analyzing over 120 biomarkers.
Blood Vision pairs lab-based testing with data from Ultrahuman’s existing wearable, the Ring AIR, giving users the ability to track markers related to cardiovascular, hormonal, metabolic, immune, and aging-related health. The platform is intended to help users monitor their health over time, rather than just through occasional or isolated checkups.
“This approach helps people better understand how their body is functioning and how it’s changing,” said Ultrahuman CEO Mohit Kumar. “By combining blood analysis with continuous data from the Ring, we can give more context to what’s happening inside the body.”
Unlike traditional lab tests, which offer results at a single point in time, Blood Vision is designed to evolve with users. The company says this allows for more personalized insights and a clearer understanding of long-term health trends.
Ultrahuman’s broader goal is to provide tools that make health monitoring more accessible and proactive. With Blood Vision, the company adds a new layer to its platform, which already includes glucose monitoring and home health tracking tools.